Laboratory of NeuroImaging, USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Alzheimer's Disease Research Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Neuroimage Clin. 2023;38:103383. doi: 10.1016/j.nicl.2023.103383. Epub 2023 Mar 20.
White matter hyperintensities (WMHs) frequently occur in Alzheimer's Disease (AD) and have a contribution from ischemia, though their relationship with β-amyloid and cardiovascular risk factors (CVRFs) is not completely understood. We used AT classification to categorize individuals based on their β-amyloid and tau pathologies, then assessed the effects of β-amyloid and tau on WMH volume and number. We then determined regions in which β-amyloid and WMH accumulation were related. Last, we analyzed the effects of various CVRFs on WMHs. As secondary analyses, we observed effects of age and sex differences, atrophy, cognitive scores, and APOE genotype. PET, MRI, FLAIR, demographic, and cardiovascular health data was collected from the Alzheimer's Disease Neuroimaging Initiative (ADNI-3) (N = 287, 48 % male). Participants were categorized as A + and T + if their Florbetapir SUVR and Flortaucipir SUVR were above 0.79 and 1.25, respectively. WMHs were mapped on MRI using a deep convolutional neural network (Sepehrband et al., 2020). CVRF scores were based on history of hypertension, systolic and diastolic blood pressure, pulse rate, respiration rate, BMI, and a cumulative score with 6 being the maximum score. Regression models and Pearson correlations were used to test associations and correlations between variables, respectively, with age, sex, years of education, and scanner manufacturer as covariates of no interest. WMH volume percent was significantly associated with global β-amyloid (r = 0.28, p < 0.001), but not tau (r = 0.05, p = 0.25). WMH volume percent was higher in individuals with either A + or T + pathology compared to controls, particularly within in the A+/T + group (p = 0.007, Cohen's d = 0.4, t = -2.5). Individual CVRFs nor cumulative CVRF scores were associated with increased WMH volume. Finally, the regions where β-amyloid and WMH count were most positively associated were the middle temporal region in the right hemisphere (r = 0.18, p = 0.002) and the fusiform region in the left hemisphere (r = 0.017, p = 0.005). β-amyloid and WMH have a clear association, though the mechanism facilitating this association is still not fully understood. The associations found between β-amyloid and WMH burden emphasizes the relationship between β-amyloid and vascular lesion formation while factors like CVRFs, age, and sex affect AD development through various mechanisms. These findings highlight potential causes and mechanisms of AD as targets for future preventions and treatments. Going forward, a larger emphasis may be placed on β-amyloid's vascular effects and the implications of impaired brain clearance in AD.
脑白质高信号(WMHs)在阿尔茨海默病(AD)中经常出现,与缺血有关,尽管其与β-淀粉样蛋白和心血管危险因素(CVRFs)的关系尚未完全清楚。我们使用 AT 分类法根据β-淀粉样蛋白和 tau 病理学对个体进行分类,然后评估β-淀粉样蛋白和 tau 对 WMH 体积和数量的影响。然后确定β-淀粉样蛋白和 WMH 积累相关的区域。最后,我们分析了各种 CVRFs 对 WMHs 的影响。作为次要分析,我们观察了年龄和性别差异、萎缩、认知评分和 APOE 基因型的影响。正电子发射断层扫描(PET)、磁共振成像(MRI)、FLAIR、人口统计学和心血管健康数据来自阿尔茨海默病神经影像学倡议(ADNI-3)(N = 287,48%为男性)。如果 Florbetapir SUVR 和 Flortaucipir SUVR 高于 0.79 和 1.25,参与者分别被归类为 A+和 T+。使用深度卷积神经网络(Sepehrband 等人,2020 年)在 MRI 上绘制 WMHs。CVRF 评分基于高血压史、收缩压和舒张压、脉搏率、呼吸率、BMI 和最高得分为 6 的累积评分。回归模型和 Pearson 相关性分别用于测试变量之间的关联和相关性,其中年龄、性别、受教育年限和扫描仪制造商作为无兴趣的协变量。WMH 体积百分比与全球β-淀粉样蛋白显著相关(r = 0.28,p < 0.001),但与 tau 无关(r = 0.05,p = 0.25)。与对照组相比,无论 A+还是 T+病理个体的 WMH 体积百分比都更高,尤其是在 A+/T+组中(p = 0.007,Cohen's d = 0.4,t = -2.5)。个体 CVRFs 或累积 CVRF 评分与 WMH 体积增加无关。最后,β-淀粉样蛋白和 WMH 计数相关性最强的区域是右半球的颞中区域(r = 0.18,p = 0.002)和左半球的梭状回区域(r = 0.017,p = 0.005)。β-淀粉样蛋白和 WMH 之间存在明确的关联,但促进这种关联的机制仍不完全清楚。在β-淀粉样蛋白和 WMH 负担之间发现的关联强调了β-淀粉样蛋白与血管病变形成之间的关系,而 CVRFs、年龄和性别等因素则通过各种机制影响 AD 的发展。这些发现突出了 AD 的潜在原因和机制,为未来的预防和治疗提供了目标。展望未来,可能会更加重视β-淀粉样蛋白的血管作用以及 AD 中脑清除能力受损的影响。